1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF ARIZONA 

IN RE: Bard IVC Filters Products 

Liability Litigation, 

No. MD-15-02641-PHX-DGC

AMENDED CASE MANAGEMENT 

ORDER NO. 5 

(Plaintiff and Defendant Profile 

Forms) 

The parties have agreed upon the use of an abbreviated Plaintiff Profile Form 

(“PPF”) (Exhibit 1) attached to this Order. Except as expressly noted herein, the PPF 

shall be completed in each currently pending case, and in all cases that become part of this 

MDL by virtue of being filed in, removed to, or transferred to this Court on or after the 

date of this Order. 

Each plaintiff in currently filed cases (except as noted herein) shall submit a 

completed PPF to defendants within 60 days of the date of this Order. In cases that have 

been filed in, removed to, or transferred to this MDL on or after the date of this Order, 

each plaintiff shall submit a completed PPF to defendants within 60 days of filing the 

complaint. 

The completed PPF shall be delivered via email to: filterppfpfs@nelsonmullins.com and to co-lead counsel via email at wespita@lopezmchugh.com

and karin.scheehle@gknet.com . 

Each plaintiff is required to provide defendants with a PPF that is substantially 

complete in all respects, answering every question in the PPF, even if a plaintiff can 

answer the question in good faith only by indicating “not applicable” or “unknown.” The 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 1 of 14
 2 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

PPF shall be signed by the plaintiff under penalty of perjury. If a plaintiff is suing in a 

representative or derivative capacity, the PPF shall be completed by the person with the 

legal authority to represent the estate or the person under legal disability. Plaintiff 

spouses with a claim for loss of consortium shall also sign the PPF, attesting that the 

responses made to the loss of consortium questions in the PPF are true and correct to the 

best of his or her knowledge, information and belief, formed after due diligence and 

reasonable inquiry. 

A completed PPF shall be considered interrogatory answers under Fed. R. Civ. P. 

33 and responses to requests for production under Fed. R. Civ. P. 34, and will be governed 

by the standards applicable to written discovery under Federal Rules 26 through 37. The 

interrogatories and requests for production in the PPF shall be answered without objection 

as to the question posed in the agreed upon PPF. This section does not prohibit a plaintiff 

from withholding or redacting information from medical or other records provided with 

the PPF based upon a recognized privilege. If information is withheld or redacted on the 

basis of privilege, plaintiff shall provide defendants with a privilege log that complies 

with Fed. R. Civ. P. 26(b)(5) simultaneously with the submission of the PPF. 

If a plaintiff does not submit a PPF within the time specified in this Order, 

defendants shall mail an overdue letter by e-mail and U.S. mail to Plaintiffs’ Co-Lead 

Counsel and the plaintiffs’ individual representative counsel, stating that defendants may 

move to dismiss that plaintiff’s case within 20 days of receipt of the letter. If no PPF is 

received within those 20 additional days, defendants may move immediately to dismiss 

that plaintiff’s case. If defendants receive a PPF that is not substantially complete, 

defendants’ counsel shall send a deficiency letter within 14 days of receipt of a PPF, as 

applicable by e-mail and U.S. mail to Plaintiffs’ Co-Lead Counsel and the plaintiffs’ 

individual representative counsel, identifying the purported deficiencies. Plaintiff shall 

have 20 days from receipt of that letter to serve a PPF that is substantially complete in all 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 2 of 14
 3 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

respects. This letter shall include sufficient detail for the parties to meet and confer 

regarding the alleged deficiencies. 

Within 45 days of receipt of a substantially complete PPF for an individual 

plaintiff, the defendants shall provide the plaintiff with a completed Defendants’ Profile 

Form (DPF) (Exhibit 2) attached to this order. A completed DPF shall be considered 

interrogatory answers under Fed. R. Civ. P. 33 and responses to requests for production 

under Fed. R. Civ. P. 34, and will be governed by the standards applicable to written 

discovery under Federal Rules 26 through 37. The interrogatories and requests for 

production in the DPF shall be answered without objection as to the question posed in the 

agreed upon DPF. This section does not prohibit a defendant from withholding or 

redacting information from medical or other records provided with the DPF based upon a 

recognized privilege. If information is withheld or redacted on the basis of privilege, 

defendants shall provide plaintiff with a privilege log that complies with Fed. R. Civ. P. 

26(b)(5) simultaneously with the submission of the DPF. 

If the plaintiff receives a DPF that is not substantially complete, plaintiff’s counsel 

shall send a deficiency letter within 14 days of receipt of a DPF, as applicable by e-mail 

and U.S. mail to Defendants’ Lead Counsel identifying the purported deficiencies. 

Defendants shall have 20 days from receipt of that letter to serve a DPF that is 

substantially complete in all respects. This letter shall include sufficient detail for the 

parties to meet and confer regarding the alleged deficiencies. 

The procedures outlined in this Order shall not apply to the following cases: 

 Plaintiff Original Jurisdiction 

1. Cason, Pamela GA – N.D. Ga. 

 1:12-cv-1288 

2. Coker, Jennifer GA – N.D. Ga. 

 1:13-cv-515 

3. Conn, Charles TX – S.D. Tex. 

 4:14-cv-298 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 3 of 14
 4 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

 Plaintiff Original Jurisdiction 

4. Ebert, Melissa PA – E.D. Pa. 

 5:12-cv-1253 

5. Fox, Susan TX – N.D. Tex. 

 3:14-cv-133 

6. Henley, Angela WI – E.D. Wis. 

 2:14-cv-59 

7. Keen, Harry PA – E.D. Pa. 

 5:13-cv-5361 

8. Milton, Gary GA – M.D. Ga. 

 5:14-cv-351 

9. Mintz, Jessica NY – E.D.N.Y. 

 2:14-v-4942 

10. Ocasio, Denise FL – M.D. Fla. 

 8:13-cv-1962 

11. Rivera (McClarty), Vicki MI – E.D. Mich. 

 4:14-cv-13627 

12. Smith, Erin TX – E.D. Tex. 

 1:13-cv-633 

13. Tillman, Lessie FL – M.D. Fla. 

 3:13-cv-222 

The parties are relieved from preparing or exchanging profile forms in those particular 

cases. 

 Dated this 2nd day of March, 2016. 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 4 of 14
EXHIBIT 1

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 5 of 14
IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF ARIZONA 

MDL No. 2641 

In Re Bard IVC Filter Products Liability Litigation 

In completing this Plaintiff Profile Form, you are under oath and must provide information that 

is true and correct to the best of your knowledge. The Plaintiff Profile Form shall be completed 

in accordance with the requirements set forth in the applicable Case Management Order. 

1. CASE INFORMATION 

Caption: Date: ----------------- -----------

Docket No.:-----------------------------

Plaintiff's attorney and Contact information: 

2. PLAINTIFF INFORMATION 

Name: ______________________________ _ 

Maiden Name: ----------------------------

Address: _____________________________ _ 

Date of birth:----------------------------

Social Security No.:--------------------------

Occupation:----------------------------

Spouse: _____________________________ _ 

Is Spouse Making Claim for Loss of Consortium? DY es D No 

3. DEVICE INFORMATION 

A. Filter Model (e.g., Recovery®, G2®, etc.):----------------

B. LotNumber: -------------------------

C. Date of Bard IVC Filter implant: ------------------

D. Attach medical evidence of product identification and operative report for filter 

placement. 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 6 of 14
E. Please check all the reasons why you believe your Bard Filter was placed: 

0 Filter Placed After Being Diagnosed with Deep Vein Thrombosis/Pulmonary 

Embolism 

0 Filter Placed in Conjunction with or before Orthopedic Procedure 

D Filter Placed in Conjunction with Trauma Situation/Motor vehicle accident 

0 Filter Placed in Conjunction with or before Bariatric Procedure 

0 Other Reason(s) for implant (explain): ----------------

0 Unknown 

0 See medical records attached 

F. Provide the name and address of both the doctor who implanted the Bard Filter and 

the hospital or medical facility at which the filter was placed: 

Doctor: ____________________________ _ 

Hospital/MedicalFacility: ______________________ _ 

~ " 

4. FAILURE MODE ALLEGED 

Please check all failure mode(s) that you allege apply to your Bard Filter: 

D Fracture 

0 Perforation of filter strut(s) into organs 

O Migration of entire filter to heart 

0 Tilt with filter embedded in wall of the IVC 

0 Device unable to be retrieved 

0 Bleeding 

0 Other failure mode(s) 

If other, please describe---------------------

5. REMOVAL INFORMATION 

A. Has your Bard Filter been removed? 

DY es 

DNo 

2 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 7 of 14
D Unknown 

B. If your Bard Filter has been removed or a doctor has attempted to remove your 

Filter, please check all that apply regarding the removal or attempted removal 

procedure(s): 

DRemoved percutaneously 

D Removed via an open abdominal procedure 

D Removed via an open chest procedure 

D Attempted but unsuccessful percutaneous removal procedure 

D Attempted but unsuccessful open abdominal procedure 

D Attempted but unsuccessful open chest procedure 

D Unknown 

D See medical records attached 

C. Provide the name(s) and address( es) of both the doctor(s) who removed your Bard 

Filter (or attempted to remove it) and the hospital or medical facility where 

removal/attempted removal occurred: 

Filter Removal/ Attempted Removal #1 

Doctor: ____________________________ _ 

Hospital/MedicalFacility: _____________________ _ 

Filter Removal/Attempted Removal #2 

Doctor: ____________________________ _ 

Hospital/MedicalFacility: _____________________ _ 

6. FRACTUREDSTRUTS 

A. Do you claim that your Bard Filter fractured? 

D Yes 

DNo 

If you answered YES, answer the below questions in this section. 

If you answered NO, skip the rest of Section 6 and go below to section 7 - "Outcome 

Attributed to Device." 

3 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 8 of 14
B. Are any fractured filter struts retained in your body? 

D Yes 

DNo 

D Unknown 

If yes, identify the location(s) within your body of each retained filter strut. 

C. Have any fractured filter struts been removed from your body? 

D Yes 

DNo 

D Unknown 

D. If any fractured filter strut has been removed (or a doctor has attempted to remove 

any strut), please check all that apply regarding the removal I attempted removal 

procedure(s): 

D Removed percutaneously 

D Removed via an open abdominal procedure 

D Removed via an open chest procedure 

D Attempted but unsuccessful percutaneous removal procedure 

D Attempted but unsuccessful open abdominal procedure 

D Attempted but unsuccessful open chest procedure 

D Unknown 

E. Provide the name and address of both the doctor who removed (or attempted to 

remove) the filter strut(s) and the hospital or medical facility at which it was 

removed (or attempted to be removed) 

Filter Strut Removal/Attempted Removal #1 

Doctor: ____________________________ _ 

4 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 9 of 14
Hospital/MedicalFacility: -----------------------

Filter Strut Removal/Attempted Removal #2 

Doctor: ----------------------------~ 

Hospital/MedicalFacility: ______________________ _ 

7. OUTCOME ATTRIBUTED TO DEVICE 

A. Do you claim to be suffering from any bodily injuries, including psychological 

injuries that are above and beyond usual pain and suffering and mental anguish, 

related to the Filter? 

D Yes 

DNo 

If your answer is "Yes," please list all symptoms and injuries you claim to have suffered: 

Of the injuries/symptoms you listed above, which do you claim to be suffering from at 

the current time: 

*** 

Plaintiff reserves the right to supplement any and all responses upon the receipt of additional 

information. 

Date 

Date 

5 

Signature of Plaintiff 

Signature of Plaintiff - Spouse (signature only 

necessary if Loss of Consortium is alleged) 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 10 of 14
EXHIBIT 2

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 11 of 14
IN THE UNITED STATES DISTRICT COURT 

FOR THE DISTRICT OF ARIZONA 

IN RE: BARD IVC FILTERS 

PRODUCTS LIABILITY LITIGATION 

MDL No. 2641 

DEFENDANT BARD CASE PROFILE FORM 

For each case, the Bard Defendants must complete this Defendant Profile Form ("DPF") 

in accordance with the schedule established by the Court's Pretrial Order. In completing this 

Profile Form, you must answer every question. 

I. CASE INFORMATION 

This defendant profile form pertains to the following case: 

Case caption:----------------------------

Civil Action No.: ---------------------------

Court in which action was originally filed: __________________ _ 

II. CONTACTS WITH IMPLANTING AND REMOVING PHYSICIANS 

Plaintiff has identified each healthcare provider who implanted, removed and/or 

attempted to remove Bard's Filter. With respect to each of those healthcare providers, provide 

the following information: 

A. CONSULTATION AGREEMENT 

1. As to the identified healthcare providers, state whether Bard has consulting 

agreement with the healthcare provider relating to IVC filters that Bard has been able 

to locate after a reasonable and diligent search. 

B. SALES REPRESENTATIVE AND OTHER RELATED CONTACTS 

As to each sales representative, territory manager and district manager who had any 

contact with an identified physician or healthcare provider, set forth the following: 

1. Identity and last known address and telephone number of Representative(s): 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 12 of 14
As to the individual who Bard believes was the territory manager and district manger for 

the territory where the filter was implanted at the time of implant, set forth the following: 

2. Identify the name of the territory manager and district manger, the dates of 

employment for each, and, if no longer employed by Bard, provide the last known 

address: 

Territory Manager: 

Employment Dates:------------------

If former, last known address: ---------------

District Manager: 

Name: -----------------------

Employment Dates:------------------

If former, last known address: ---------------

III. MANUFACTURING INFORMATION 

A. Identify the lot number(s) for the Bard filter implanted in Plaintiff: 

B. Identify the lot number for the Bard device used to remove or used to attempt to remove 

the Bard Filter implanted into Plaintiff: 

C. Identify the location and date of manufacture for each lot set forth in response to A and B 

above: -----------------------------

IV. DOCUMENTS 

A. Please produce the following: 

1. The Device History Record (DHR) for the Bard filter at issue, or, if already produced, 

provide the bates number for the DHR. 

2 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 13 of 14
2. The Bard complaint file relating to plaintiffs claims, or, in the alternative if already 

produced, provide the bates number for the complaint. 

3. The bates numbers for any documents previously produced that reference the 

implanting physician and/or the hospital or facility where the device as placed, that 

Bard is able to identify after a reasonable and diligent search. 

4. Any consulting agreement relating to IVC filters that Bard has entered with the 

physician that implanted the filter. 

5. With regard to the plaintiff, any Med Watch Adverse Event Reports in Bard's 

possession. 

Attorney for C.R. Bard, Inc. and Bard Peripheral Vascular, Inc. 

[Signature] 

3 

Case 2:15-md-02641-DGC Document 927 Filed 03/03/16 Page 14 of 14